These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7490730)

  • 1. N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists.
    Salimbeni A; Canevotti R; Paleari F; Poma D; Caliari S; Fici F; Cirillo R; Renzetti AR; Subissi A; Belvisi L
    J Med Chem; 1995 Nov; 38(24):4806-20. PubMed ID: 7490730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
    Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
    Eur J Pharmacol; 1995 Apr; 277(2-3):223-8. PubMed ID: 7493612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
    Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonist.
    Renzetti AR; Criscuoli M; Salimbeni A; Subissi A
    Eur J Pharmacol; 1995 Jul; 290(2):151-6. PubMed ID: 8575530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
    Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
    Eur J Pharmacol; 1996 Jul; 307(3):259-67. PubMed ID: 8836613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
    Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
    J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists.
    Nicolaï E; Curé G; Goyard J; Kirchner M; Teulon JM; Versigny A; Cazes M; Caussade F; Virone-Oddos A; Cloarec A
    J Med Chem; 1994 Jul; 37(15):2371-86. PubMed ID: 8057285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).
    Deprez P; Guillaume J; Becker R; Corbier A; Didierlaurent S; Fortin M; Frechet D; Hamon G; Heckmann B; Heitsch H
    J Med Chem; 1995 Jun; 38(13):2357-77. PubMed ID: 7608902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
    Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Diazinyl- and 4-pyridinylimidazoles: potent angiotensin II antagonists. A study of their activity and computational characterization.
    Harmat NJ; Giorgi R; Bonaccorsi F; Cerbai G; Colombani SM; Renzetti AR; Cirillo R; Subissi A; Alagona G; Ghio C
    J Med Chem; 1995 Jul; 38(15):2925-37. PubMed ID: 7636853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
    Kubo K; Kohara Y; Imamiya E; Sugiura Y; Inada Y; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jul; 36(15):2182-95. PubMed ID: 8340921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives.
    Bradbury RH; Allott CP; Dennis M; Girdwood JA; Kenny PW; Major JS; Oldham AA; Ratcliffe AH; Rivett JE; Roberts DA
    J Med Chem; 1993 Apr; 36(9):1245-54. PubMed ID: 8487261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
    Kim TW; Yoo BW; Lee JK; Kim JH; Lee KT; Chi YH; Lee JY
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1649-54. PubMed ID: 22264484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
    Ashton WT; Hutchins SM; Greenlee WJ; Doss GA; Chang RS; Lotti VJ; Faust KA; Chen TB; Zingaro GJ; Kivlighn SD
    J Med Chem; 1993 Nov; 36(23):3595-605. PubMed ID: 8246227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
    Ashton WT; Cantone CL; Chang LL; Hutchins SM; Strelitz RA; MacCoss M; Chang RS; Lotti VJ; Faust KA; Chen TB
    J Med Chem; 1993 Mar; 36(5):591-609. PubMed ID: 8496939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.
    Ashton WT; Chang LL; Flanagan KL; Hutchins SM; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ; Chen TB; Faust KA
    J Med Chem; 1994 Aug; 37(17):2808-24. PubMed ID: 8064808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
    Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
    J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.